Find uplifting stories about heroes, innovations, and solutions
8252 results for "obesity treatment"
The American Medical Association just adopted sweeping policies to make weight loss medications and comprehensive obesity care more affordable for millions of Americans. The move addresses one of healthcare's biggest cost barriers while recognizing obesity as a chronic disease requiring long-term support.
A South Korean pharmaceutical company just secured the biggest tech deal in the nation's history for an obesity drug that keeps muscle while burning fat. This breakthrough could transform how millions lose weight safely.
A breakthrough obesity treatment helped patients lose nearly 30% of their body weight—results previously only achievable through surgery. The experimental drug could transform how millions manage obesity while Medicare makes these treatments more affordable.
Children who gained uncontrollable weight after brain tumor treatment now have hope. A new FDA-approved medication addresses the root cause of their constant hunger and rapid weight gain.
France just became the first EU country to cover breakthrough obesity medications for severely obese patients, helping one million people access treatments that previously cost €300 per month. The bold public health move recognizes obesity as a serious medical condition deserving national support.
Eli Lilly has granted one person extraordinary access to its next-generation obesity treatment through an FDA compassionate use program. The decision marks a rare exception that could offer hope to patients waiting for breakthrough treatments.
Doctors are discovering why weight-loss drugs work brilliantly for some people but fail for others. The answer could revolutionize how we treat obesity within just a few years.
A new class of medications is transforming obesity treatment by working with the body's hunger signals rather than against them, helping patients lose up to 30% of their body weight. These GLP-1 drugs are proving that obesity has deep biological roots beyond willpower alone.
Millions of Americans struggling with obesity now have a new option: the FDA just approved Foundayo, the first oral tablet in a groundbreaking class of weight-loss medications. This pill could transform treatment by offering an easier alternative to weekly injections.
Scientists are developing obesity medications that prioritize fewer side effects and better long-term health outcomes over extreme weight loss. Yale researchers say the next generation of treatments could preserve muscle and bone while helping millions stick with their medications.
A new obesity treatment that only requires monthly injections continues to show promising results, offering hope for easier weight loss options. Patients in a recent study lost over 12% of their body weight without hitting a plateau.
%2Ffile%2Fattachments%2F2992%2F13971407_975900.jpg)
Starting mid-June, France becomes the first EU nation to reimburse life-changing weight-loss medications for severely obese patients. Up to one million people could access treatments that currently cost €300 monthly out of pocket.
Doctors at Mayo Clinic are successfully pairing weight loss surgery with medications like Ozempic to help patients overcome obesity. This combined approach offers new hope for people who need more support than one treatment alone can provide.
A new experimental obesity treatment targeting three hormones has shown significant weight loss in early testing. The "triple-G" drug from Kailera offers fresh hope in the rapidly expanding field of weight management medicine.
Researchers created a groundbreaking tool that predicts obesity complications more accurately than BMI alone, considering family history, diet, and lifestyle factors. The advancement could help millions get the right treatment at the right time.
A new obesity treatment from pharmaceutical company Boehringer has shown promising results, helping patients lose an average of 16.6% of their body weight in clinical trials. The breakthrough adds another tool to the growing arsenal of effective weight loss medications changing lives worldwide.
A new, stronger version of the popular weight loss medication Wegovy just got FDA approval, giving more Americans access to potentially more effective obesity treatment. The approval came through a new fast-track program designed to speed up medicines that address major health priorities.
Eli Lilly is building a $3.5 billion manufacturing facility in Pennsylvania to produce breakthrough obesity treatments, including an experimental drug showing record-breaking weight loss results. The plant will create 850 permanent jobs and 2,000 construction positions when it opens in 2031.
Bollywood actor Kunal Kapoor has launched MetaGO, a new healthcare platform that treats obesity as a long-term medical condition requiring ongoing doctor support, not just quick fixes. The venture combines specialist care, advanced diagnostics, and personalized treatment plans to help people tackle metabolic health before it becomes a crisis.
More than 10 million Americans just regained insurance coverage for a life-changing obesity treatment after CVS reversed its restrictions on Zepbound. The win came after drugmaker Eli Lilly slashed prices to make the medication more accessible.
Showing 20 of 8252